2020
DOI: 10.1038/s41467-019-14139-5
|View full text |Cite
|
Sign up to set email alerts
|

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

Abstract: Carbapenem-resistant Enterobacteriaceae (CRE) represent an urgent threat to human health. Here we report the application of several complementary whole-genome sequencing (WGS) technologies to characterise a hospital outbreak of blaIMP-4 carbapenemase-producing E. hormaechei. Using Illumina sequencing, we determined that all outbreak strains were sequence type 90 (ST90) and near-identical. Comparison to publicly available data linked all outbreak isolates to a 2013 isolate from the same ward, suggesting an envi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
52
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(55 citation statements)
references
References 69 publications
3
52
0
Order By: Relevance
“…Carbapenems are considered the drug of choice in treating such infections. However, the increased usage of these antibiotics has led to the emergence of carbapenem-resistant strains ( Roberts et al, 2020 ). Center for Disease Control (CDC) considers carbapenem-resistant Enterobacterales (CRE) as a serious global threat to patient health that limits treatment options, especially in chronically ill patients in intensive care units (ICU) and long-term care facilities ( McConville et al, 2017 ; Gupta et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Carbapenems are considered the drug of choice in treating such infections. However, the increased usage of these antibiotics has led to the emergence of carbapenem-resistant strains ( Roberts et al, 2020 ). Center for Disease Control (CDC) considers carbapenem-resistant Enterobacterales (CRE) as a serious global threat to patient health that limits treatment options, especially in chronically ill patients in intensive care units (ICU) and long-term care facilities ( McConville et al, 2017 ; Gupta et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Resistance to carbapenems in Enterobacteriaceae occurs via one or a combination of carbapenemase production, production of ESBLs and/or AmpC in combination with porin loss/deficiency, carbapenem efflux, or mutations in penicillin-binding proteins (PBPs) [6,7], among which carbapenemase gene acquisition is of greatest concern [8], as it most frequently occurs via transfer of plasmids, which usually co-harbor β-lactamases and other resistance determinants, rendering these carbapenemase-producing Enterobacteriaceae (CPE) strains multi-drug resistant (MDR) or extensively drug-resistant (XDR) [9]. CPE is the most problematic due to higher-level antimicrobial resistance, clonal spread and horizontal gene transfer [10].…”
Section: Introductionmentioning
confidence: 99%
“…Resistance to carbapenems in Enterobacteriaceae occurs via one or a combination of the following four mechanisms: carbapenemase production, production of ESBLs and/or AmpC in combination with porin loss/deficiency, carbapenem efflux, or mutations in penicillin-binding proteins (PBPs) [6,7], among which carbapenemase gene acquisition is of greatest concern [8], as it most frequently occurs via transfer of plasmids, which usually co-harbor β-lactamases and other resistance determinants, rendering these carbapenemase-producing Enterobacteriaceae (CPE) strains multi-drug resistance (MDR) or extensively drug-resistant (XDR) [9]. CPE is the most problematic owing to higher-level antimicrobial resistance, clonal spread and horizontal gene transfer [10].…”
Section: Introductionmentioning
confidence: 99%